Evaluation of asthma medication adherence rates and strategies to improve adherence in the underserved population at a Federally Qualified Health Center

被引:54
作者
Bidwal, Monica [1 ]
Lor, Kajua [1 ]
Yu, Junhua [1 ]
Ip, Eric [1 ]
机构
[1] Touro Univ Calif, Coll Pharm, 1310 Club Dr, Vallejo, CA 94592 USA
关键词
Asthma; Adherence; Underserved; 340B; Federally Qualified Health Center; DRUG-THERAPY; NONADHERENCE; PREDICTORS; COHORT; PREVALENCE; PHYSICIAN; BARRIERS; PATIENT; LATINO; RISK;
D O I
10.1016/j.sapharm.2016.07.007
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Adherence with asthma medications is less than optimal, measuring approximately 30-50%. Several factors have been shown to contribute to medication non-adherence including low-socioeconomic status, low literacy, medication cost, access to care, and language barriers. Community Health Clinic Ole has attempted to reduce medication adherence barriers associated with cost, access to care, and language by 1) allowing medications to be obtained from the clinic at a reduced cost via the 340B drug pricing program and patient assistance programs, and 2) providing one-on-one consultations from bilingual Spanish-speaking clinicians. Limited evidence is available regarding chronic disease-state medication adherence among Spanish-speaking individuals presenting to a Federally Qualified Health Center (FQHC). Objective: The purpose of this study is to assess asthma medication adherence and determine predictors of non-adherence in the underserved population at an FQHC. Methods: Adult patients with a diagnosis of persistent asthma receiving medication refills from clinic between October 1, 2011 and October 31, 2012 were identified (N = 121). Individuals with intermittent or seasonal asthma only, exercise-induced asthma only, or mixed asthma/COPD; individuals who have not picked up at least one fill of inhaled corticosteroid in the past one-year; and individuals without active prescriptions for asthma controller medications were excluded. Medication adherence was assessed by using the medication possession ratio (MPR) for asthma controller medications (e.g. inhaled corticosteroids, long-acting beta-2 agonists, leukotriene modifiers, and theophylline). Patients were categorized into two adherence groups: medium high (MPR >= 0.5) and low (MPR < 0.5). Results: Approximately one-third of individuals were identified with medium high adherence to asthma medications, of which only 8.3% of individuals were found to be fully adherent (MPR >= 0.8). The majority of individuals (66.1%) were identified with low adherence, despite efforts to reduce medication adherence barriers associated with drug cost, access to care, and language. Patients with low adherence were younger (39.3 vs. 45.4 yo; P < 0.012), had fewer medication refills (2.1 vs. 5.3; P < 0.001), had fewer primary care provider (PCP) visits (3.4 vs. 5.0; P < 0.05), lower baseline Asthma Control Test (ACT) scores (13.1 vs. 17.3; P < 0.001), and lower asthma medication ratios (AMR) (0.7 vs. 0.9; P < 0.001) than patients with medium-high adherence. No significant differences in MPR rates were found between Hispanics and non-Hispanics. The average MPR in both groups was 0.55. Conclusion: Our findings demonstrate that asthma medication adherence remains poor among all underserved patients despite improved access to care via reduced medication pricing and the provision of Spanish-speaking medication consultations at refill pick-ups. Poor adherence rates remained common among both the Non-Hispanic and Hispanic, younger, and lower-socioeconomic patients in our study. Future studies may wish to explore whether providing a service that encompasses healthcare team support, optimal medication counseling, and utilization of patient-centered communication strategies improves asthma medication adherence in the Hispanic population. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:759 / 766
页数:8
相关论文
共 32 条
[1]  
[Anonymous], 2012, HELP AM ASTHM
[2]  
[Anonymous], 2011, GINA REP
[3]   Overcoming barriers to nonadherence in asthma treatment [J].
Bender, BG .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 109 (06) :S554-S559
[4]   Patients at-risk for cost-related medication nonadherence: A review of the literature [J].
Briesacher, Becky A. ;
Gurwitz, Jerry H. ;
Soumerai, Stephen B. .
JOURNAL OF GENERAL INTERNAL MEDICINE, 2007, 22 (06) :864-871
[5]   Asthma disparities in urban environments [J].
Bryant-Stephens, Tyra .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (06) :1199-1206
[6]   Patient, Physician, and Payment Predictors of Statin Adherence [J].
Chan, David C. ;
Shrank, William H. ;
Cutler, David ;
Jan, Saira ;
Fischer, Michael A. ;
Liu, Jun ;
Avorn, Jerry ;
Solomon, Daniel ;
Brookhart, Alan ;
Choudhry, Niteesh K. .
MEDICAL CARE, 2010, 48 (03) :196-202
[7]   Identification of barriers to medication adherence in a Latino population [J].
Compton, Sheryl ;
Haack, Sally ;
Phillips, Charles R. .
RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2010, 6 (04) :365-371
[8]   Adherence to controller asthma medications: 6-month prevalence across a US community pharmacy chain [J].
Feehan, M. ;
Ranker, L. ;
Durante, R. ;
Cooper, D. K. ;
Jones, G. J. ;
Young, D. C. ;
Munger, M. A. .
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2015, 40 (05) :590-593
[9]   Race/ethnicity and nonadherence to prescription medications among seniors: Results of a national study [J].
Gellad, Walid F. ;
Haas, Jennifer S. ;
Safran, Dana Gelb .
JOURNAL OF GENERAL INTERNAL MEDICINE, 2007, 22 (11) :1572-1578
[10]  
Halpern Becker R, 2009, ARTHRITIS RHEUM S, V60, P860